Cross talk between P2 purinergic receptors modulates extracellular ATP-mediated interleukin-10 production in rat microglial cells

被引:0
作者
Dong Reoyl Seo
Soo Yoon Kim
Kyung You Kim
Hwan Goo Lee
Ju Hyun Moon
Jae Souk Lee
Se Hoon Lee
Seung U Kim
Yong Beom Lee
机构
[1] Neuroscience Graduate Program,BK21 Division of Cell Transformation and Restoration
[2] Ajou University School of Medicine,Division of Neurology, Department of Medicine
[3] Suwon 443-721,undefined
[4] Korea.,undefined
[5] Ajou University School of Medicine,undefined
[6] Suwon 443-721,undefined
[7] Korea.,undefined
[8] Brain Disease Research Center,undefined
[9] Ajou University School of Medicine,undefined
[10] Suwon 443-721,undefined
[11] Korea.,undefined
[12] University of British Columbia,undefined
[13] Vancouver,undefined
[14] British Columbia,undefined
[15] Canada V6T 1Z3.,undefined
来源
Experimental & Molecular Medicine | 2008年 / 40卷
关键词
adenosine diphosphate; adenosine triphosphate; calcium; cyclic AMP; cyclic AMP-dependent protein kinases; inositol 3-phosphate; interleukin-10; microglia; receptors, purinergic P2;
D O I
暂无
中图分类号
学科分类号
摘要
Previously we demonstrated that ATP released from LPS-activated microglia induced IL-10 expression in a process involving P2 receptors, in an autocrine fashion. Therefore, in the present study we sought to determine which subtype of P2 receptor was responsible for the modulation of IL-10 expression in ATP-stimulated microglia. We found that the patterns of IL-10 production were dose-dependent (1, 10, 100, 1,000 µM) and bell-shaped. The concentrations of ATP, ATP-γS, ADP, and ADP-βS that showed maximal IL-10 release were 100, 10, 100, and 100 µM respectively. The rank order of agonist potency for IL-10 production was 2'-3'-O-(4-benzoyl)-benzoyl ATP (BzATP) = dATP > 2-methylthio-ADP (2-meSADP). On the other hand, 2-methylthio-ATP (2-meSATP), α,β-methylene ATP (α,β-meATP), UTP, and UDP did not induce the release of IL-10 from microglia. Further, we obtained evidence of crosstalk between P2 receptors, in a situation where intracellular Ca2+ release and/or cAMP-activated PKA were the main contributors to extracellular ATP-(or ADP)-mediated IL-10 expression, and IL-10 production was down-regulated by either MRS2179 (a P2Y1 antagonist) or 5'-AMPS (a P2Y11 antagonist), indicating that both the P2Y1 and P2Y11 receptors are major receptors involved in IL-10 expression. In addition, we found that inhibition of IL-10 production by high concentrations of ATP-γS (100 µM) was restored by TNP-ATP (an antagonist of the P2X1, P2X3, and P2X4 receptors), and that IL-10 production by 2-meSADP was restored by 2meSAMP (a P2Y12 receptor antagonist) or pertussis toxin (PTX; a Gi protein inhibitor), indicating that the P2X1, P2X3, P2X4 receptor group, or the P2Y12 receptor, negatively modulate the P2Y11 receptor or the P2Y1 receptor, respectively.
引用
收藏
页码:19 / 26
页数:7
相关论文
共 147 条
[1]  
Abbracchio MP(2006)International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy Pharmacol Rev 58 281-341
[2]  
Burnstock G(1999)Opposite effects of interferon-γ and prostaglandin E J Neurosci Res 56 571-580
[3]  
Boeynaems JM(2006) on tumor necrosis factor and interleukin-10 production in microglia: a regulatory loop controlling microglia pro- and anti-inflammatory activities Curr Med Chem 13 289-312
[4]  
Barnard EA(1995)P2 receptors activated by uracil nucleotides--an update J Biol Chem 270 30849-30852
[5]  
Boyer JL(1997)Cloning and functional expression of a human uridine nucleotide receptor J Biol Chem 272 31969-31973
[6]  
Kennedy C(1999)Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase Br J Pharmacol 128 1199-1206
[7]  
Knight GE(2001)Pharmacological characterization of the human P2Y11 receptor J Biol Chem 276 41479-41485
[8]  
Fumagalli M(1999)Identification of a novel human ADP receptor coupled to G Prog Brain Res 120 355-368
[9]  
Gachet C(2002)The P2Z/P2X7 receptor of microglial cells: a novel immunomodulatory receptor Br J Pharmacol 135 831-842
[10]  
Jacobson KA(2004)P2 receptors: new potential players in atherosclerosis J Immunol 173 7539-7539